Significant Ownership of Andrew J. Schwab
- Location
- San Francisco, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Andrew J. Schwab.
Follow Filing Activity
Follow Andrew J. Schwab and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Andrew J. Schwab
Significant Ownership of Andrew J. Schwab
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SKYE | SKYE BIOSCIENCE, INC. | Common Stock, par value $0.001 | 34% | $15,119,125 | -$203,807 | 11,541,317 | -1.3% | Andrew J. Schwab | 12 Dec 2025 |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Common Stock | 12% | $8,392,800 | 5,869,091 | Andrew J. Schwab | 09 Sep 2025 | ||
| Rallybio Corp | Common Stock, par value $0.0001 per share | 5.5% | 291,788 | Andrew J. Schwab | 25 Feb 2026 | ||||
| VOR | VOR BIOPHARMA INC. | Common Stock, par value $0.0001 per share | 3.5% | $4,422,863 | 4,422,863 | Andrew J. Schwab | 08 Jul 2025 |
Schedules 13D/G Reported by Andrew J. Schwab:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.